Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
BRNS:NASDAQ
Barinthus Biotherapeutics PLC - ADR
$0.64
+0.47%
(+0.0030) 1D
Apr 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRNS...
Open
$0.68
High
$0.68
Low
$0.60
Mkt. cap
26.18M
Avg. vol.
28.82K
Volume
7.68K
52-wk high
$2.92
52-wk low
$0.51
EPS
-$1.64
Beta
-0.61
Shares outstanding
40.85M
No. of employees
14
News stories
From sources across the web
Profile
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
About Barinthus Biotherapeutics PLC - ADR
CEO-
Employees14
Founded2016
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
68.00K
-1.00K
-308.00K
374.00K
Cost of revenue
68.00K
-1.00K
-308.00K
374.00K
Research and development expenses
7.92M
6.61M
5.46M
3.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.64M
15.38M
5.15M
1.50M
Operating expense
20.53M
21.98M
10.53M
4.51M
Total operating expenses
20.60M
21.98M
10.23M
4.88M
Operating income
-20.60M
-21.98M
-10.23M
-4.88M
Other non operating income
75.00K
320.00K
-275.00K
-104.00K
EBT including unusual items
-19.68M
-21.15M
-14.64M
-11.16M
EBT excluding unusual items
-19.98M
-21.15M
-10.04M
-4.59M
Income tax expense
-22.00K
-25.00K
-71.00K
-57.00K
Effective tax rate
0.11%
0.12%
0.48%
0.51%
Other operating expenses
-29.00K
-13.00K
-72.00K
-434.00K
Net income
-19.65M
-21.12M
-14.57M
-11.09M
Net profit margin
-
-
-
-
Earnings per share
-0.49
-0.52
-0.24
-0.27
Interest and investment income
556.00K
523.00K
472.00K
406.00K
Interest expense
-13.00K
-12.00K
-13.00K
-13.00K
Net interest expenses
543.00K
511.00K
459.00K
393.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.36M
-20.78M
-10.12M
-4.57M
Gain or loss from assets sale
-
-281.00K
-68.00K
104.00K
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more